A carregar...

Navigating the road towards optimal initial therapy for chronic myeloid leukemia

PURPOSE OF REVIEW: Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia (CML) and are now widely accepted as the initial therapy of choice in this disease, supplanting interferon and allogeneic stem cell transplantation. There are currently three drugs appr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Okimoto, Ross A., Van Etten, Richard A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3496274/
https://ncbi.nlm.nih.gov/pubmed/21252655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0b013e32834399a5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!